feed,title,long_url,short_url
SeekingAlpha,FDA puts DiaMedica's phase 2/3 trial for its stroke treatment DM199 on clinical hold,https://seekingalpha.com/news/3854810,
SeekingAlpha,"AbbVie lowers Q2 and FY 2022 guidance on acquired R&D assets, milestones expense",https://seekingalpha.com/news/3854809,
